The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((4-Methoxyphenyl)(phenyl)methylene)-N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)hydrazinecarboxamide ID: ALA3330911
PubChem CID: 118713308
Max Phase: Preclinical
Molecular Formula: C30H33N5O3
Molecular Weight: 511.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(/C(=N/NC(=O)NCCCC(C)Nc2cc(OC)cc3cccnc23)c2ccccc2)cc1
Standard InChI: InChI=1S/C30H33N5O3/c1-21(33-27-20-26(38-3)19-24-12-8-17-31-29(24)27)9-7-18-32-30(36)35-34-28(22-10-5-4-6-11-22)23-13-15-25(37-2)16-14-23/h4-6,8,10-17,19-21,33H,7,9,18H2,1-3H3,(H2,32,35,36)/b34-28+
Standard InChI Key: RTFXOYWRTBJVAJ-CDSHQWRTSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
0.7545 -7.8191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4882 -8.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4882 -9.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7545 -9.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0746 -9.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0746 -8.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6550 -9.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6550 -10.3022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0746 -10.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8042 -10.3022 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2178 -9.4233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8975 -9.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8975 -8.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6230 -9.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3526 -9.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0822 -9.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8118 -8.9881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4915 -9.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2253 -8.9881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9051 -9.3777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6306 -8.9881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3104 -9.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3104 -10.2026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0399 -10.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7198 -10.2026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7198 -9.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0399 -8.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4494 -10.5923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1831 -10.2026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6306 -8.1631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3104 -7.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3104 -6.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6306 -6.5092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9051 -6.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9051 -7.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4915 -10.2026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7545 -6.9942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0249 -6.5589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
1 6 1 0
5 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
4 10 1 0
3 11 1 0
12 11 1 0
13 12 1 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
28 29 1 0
21 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
18 36 2 0
1 37 1 0
37 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 511.63Molecular Weight (Monoisotopic): 511.2583AlogP: 5.58#Rotatable Bonds: 11Polar Surface Area: 96.87Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.70CX Basic pKa: 4.08CX LogP: 4.86CX LogD: 4.86Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.14Np Likeness Score: -0.82
References 1. Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B.. (2014) Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity., 86 [PMID:25203780 ] [10.1016/j.ejmech.2014.09.013 ] 2. Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B.. (2018) Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity., 146 [PMID:29407988 ] [10.1016/j.ejmech.2018.01.062 ] 3. Pavić K, Perković I, Pospíšilová Š, Machado M, Fontinha D, Prudêncio M, Jampilek J, Coffey A, Endersen L, Rimac H, Zorc B.. (2018) Primaquine hybrids as promising antimycobacterial and antimalarial agents., 143 [PMID:29220797 ] [10.1016/j.ejmech.2017.11.083 ]